Jones Financial Companies Lllp Eli Lilly & CO Transaction History

Jones Financial Companies Lllp

$97.4 Billion
Q3 2024

A detailed history of Jones Financial Companies Lllp transactions in Eli Lilly & CO stock. As of the latest transaction made, Jones Financial Companies Lllp holds 87,192 shares of LLY stock, worth $69.4 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

87,192

Previous 53,172 63.98%

Holding current value

$69.4 Million

Previous $48.1 Million 60.46%

% of portfolio

0.08%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $26.3 Million - $32.7 Million	34,020 Added 63.98%	87,192 $77.2 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $25.5 Million - $31.9 Million	35,131 Added 194.73%	53,172 $48.1 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $5.34 Million - $7.14 Million	9,017 Added 99.92%	18,041 $14 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $1.03 Million - $1.22 Million	1,967 Added 27.87%	9,024 $5.26 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $380,362 - $524,387	-875 Reduced 11.03%	7,057 $3.79 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $68,745 - $91,920	-196 Reduced 2.41%	7,932 $3.72 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $73,308 - $86,097	-236 Reduced 2.82%	8,128 $2.79 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $38,586 - $44,960	-120 Reduced 1.41%	8,364 $3.06 Million
Q3 2022 Nov 03, 2022	SELL	$296.48 - $337.87 $219,988 - $250,699	-742 Reduced 8.04%	8,484 $2.74 Million
Q2 2022 Aug 08, 2022	SELL	$278.73 - $327.27 $150,792 - $177,053	-541 Reduced 5.54%	9,226 $2.99 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $111,243 - $138,246	-474 Reduced 4.63%	9,767 $2.8 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $604,396 - $750,059	2,688 Added 35.59%	10,241 $2.83 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $169,080 - $208,077	-763 Reduced 9.18%	7,553 $1.75 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $129,273 - $167,214	716 Added 9.42%	8,316 $1.91 Million
Q1 2021 Apr 30, 2021	BUY	$164.32 - $212.72 $179,273 - $232,077	1,091 Added 16.76%	7,600 $1.42 Million
Q4 2020 Feb 08, 2021	BUY	$130.46 - $172.63 $111,151 - $147,080	852 Added 15.06%	6,509 $1.1 Million
Q3 2020 Oct 29, 2020	SELL	$146.22 - $169.13 $149,436 - $172,850	-1,022 Reduced 15.3%	5,657 $838,000
Q2 2020 Jul 31, 2020	BUY	$136.42 - $164.18 $15,688 - $18,880	115 Added 1.75%	6,679 $1.1 Million
Q1 2020 May 01, 2020	SELL	$119.05 - $147.35 $22,143 - $27,407	-186 Reduced 2.76%	6,564 $910,000
Q4 2019 Jan 21, 2020	SELL	$106.92 - $132.43 $1,924 - $2,383	-18 Reduced 0.27%	6,750 $887,000
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $47,307 - $51,458	-443 Reduced 6.14%	6,768 $757,000
Q2 2019 Aug 02, 2019	BUY	$110.79 - $129.32 $67,138 - $78,367	606 Added 9.17%	7,211 $799,000
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $114,760 - $135,081	-1,031 Reduced 13.5%	6,605 $858,000
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $140,741 - $157,672	-1,329 Reduced 14.82%	7,636 $884,000
Q3 2018 Nov 08, 2018	SELL	$85.86 - $107.31 $12,964 - $16,203	-151 Reduced 1.66%	8,965 $962,000
Q2 2018 Aug 08, 2018	SELL	$75.7 - $86.88 $76,759 - $88,096	-1,014 Reduced 10.01%	9,116 $778,000
Q1 2018 May 11, 2018	SELL	$74.21 - $87.6 $33,691 - $39,770	-454 Reduced 4.29%	10,130 $784,000
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $38,184 - $40,956	-466 Reduced 4.22%	10,584 $894,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $37,224 - $41,315	483 Added 4.57%	11,050 $946,000
Q2 2017 Aug 14, 2017	BUY	N/A	10,567	10,567 $870,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.

Account

Jones Financial Companies Lllp Eli Lilly & CO Transaction History